Abstract
Background Clinical diagnostic assessments and outcome monitoring of patients with depression rely predominantly on interviews by professionals and the use of self-report questionnaires. The ubiquity of smartphones and other personal consumer devices has prompted research into the potential of data collected via these devices to serve as digital behavioral markers for indicating presence and monitoring of outcome of depression.
Objective This paper explores the potential of using behavioral data collected with mobile phones to detect and monitor depression symptoms in patients diagnosed with depression.
Methods In a prospective cohort study, we collected smartphone behavioral data for up to one year. The study consists of observations from 99 subjects, including healthy controls (n=25) and patients diagnosed with various depressive disorders: major depressive disorder (MDD) (n=46), major depressive disorder with comorbid borderline personality disorder (MDD|BPD) (n=16), and bipolar disorder with major depressive episodes (MDE|BD) (n=12). Data were labeled based on depression severity, using the 9-item Patient Health Questionnaire (PHQ-9) scores. We performed statistical analysis and employed supervised machine learning on the data to classify the severity of depression and observe changes in the depression state over time.
Results We identified 32 behavioral markers associated with the changes in depressive state. Our analysis classified depressed subjects with an accuracy of 82% and depression state transitions with an accuracy of 75%.
Conclusions The use of mobile phone digital behavioral markers to supplement clinical evaluations may aid in detecting the presence and relapse of clinical depression and monitoring its outcome, particularly if combined with intermittent use of self-report of symptoms.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics committee of the Helsinki and Uusimaa Hospital District gave ethics approval for this work
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
Due to the highly sensitive and private nature of the data, the data collected in this study cannot be shared with researchers outside of our consortium.
Abbreviations
- BDI-II
- Beck Depression Inventory-II
- CI
- Confidence Interval
- FDR
- False Discovery Rate
- GEE
- Generalized Estimating Equations
- GPS
- Global Positioning System
- HUS
- Helsinki and Uusimaa Hospital District
- KNN
- K-Nearest Neighbors
- MADRS
- Montgomery-Åsberg Depression Rating Scale
- MDD
- Major Depressive Disorder
- MDD|BPD
- Major Depressive Disorder with Comorbid Borderline Personality Disorder
- MDE|BD
- Major Depressive Episodes with Bipolar Disorder
- MINI
- Mini-International Neuropsychiatric Interview
- NPV
- Negative Predictive Value
- OPTUNA
- Optimization Framework
- PHQ-4
- 4-item Patient Health Questionnaire
- PHQ-9
- 9-item Patient Health Questionnaire
- PPV
- Positive Predictive Value
- SMOTE
- Synthetic Minority Over-sampling Technique
- SHAP
- SHapley Additive exPlanations
- SVC
- Support Vector Classifier
- XGBoost
- Extreme Gradient Boosting
